Marcus Hentrich

Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study

Klaus‐Peter Dieckmann, Arlo Radtke, Lajos Géczi et al. · Journal of Clinical Oncology · 2019 · 343 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

J. Beyer, Peter Albers, Renske Altena et al. · Annals of Oncology · 2012 · 322 citations · Full text

Medicine, Oncology, Cancer Survivorship Care +10

Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium

Silke Gillessen, Nicolas Sauvé, Laurence Collette et al. · Journal of Clinical Oncology · 2021 · 238 citations · Full text

Medicine, Oncology, Chemotherapy +15

Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium

J. Beyer, Laurence Collette, Nicolas Sauvé et al. · Journal of Clinical Oncology · 2021 · 171 citations · Full text

Medicine, Oncology, Chemotherapy +12

A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly)

Veronika Ballová, Jens Ulrich Rüffer, Heinz Haverkamp et al. · Annals of Oncology · 2004 · 159 citations

Medicine, Geriatric Medicine, Geriatrics +3